Glymphatic system: a pathway for managing endogenous metabolites in CNS

Glymphatic system: a pathway for managing endogenous metabolites in CNS

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2017.

Библиографические подробности
Главный автор:	Tasneem, Sadia
Другие авторы:	Archie, Sabrina Rahman
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2021
Предметы:	Glymphatic pathway Alzheimer’s disease CNS Molecular diagnosis Alzheimer's disease > Diagnosis
Online-ссылка:	http://hdl.handle.net/10361/14373

Схожие документы

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
по: Chowdhury, Sariya Uzrat
Опубликовано: (2022)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
по: Aziz, Farhin
Опубликовано: (2019)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
по: Saha, Bithi Rani
Опубликовано: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
по: Afra, Sumaiya
Опубликовано: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
по: Tabassum, Nadira
Опубликовано: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
по: Karmaker, Swastika
Опубликовано: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
по: Shehab, Habibul Mohsin
Опубликовано: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
по: Mahee, Sadique Abdal
Опубликовано: (2024)

Role of circular RNA in neurological disease
по: Salsabil, Labiba
Опубликовано: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
по: Tamanna, Mst. Taskia
Опубликовано: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
по: Jahan, Nusrat
Опубликовано: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
по: Tasin, Md Abtahi
Опубликовано: (2023)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
по: Mostofa, Golam
Опубликовано: (2022)

Alzheimer's disease and marriage : an intimate account /
по: Wright, Lore K.
Опубликовано: (1993)

Potential treatments for epigenetic dysregulation in neurological diseases
по: Zaman, Rubaiyat
Опубликовано: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
по: Dey, Manashi
Опубликовано: (2024)

A literature review on the efficacy of test kits for COVID-19
по: Sajid, Saiara Sajita
Опубликовано: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
по: Aana, Afsara Sumon
Опубликовано: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
по: Halim, Rabea
Опубликовано: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
по: Ferdous, Labiba
Опубликовано: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
по: Rahman, Quazi Ashikur, и др.
Опубликовано: (2022)

Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022)

Skeleton /
по: Parkin, Peter

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

An ambient assisted living system for Alzheimer’s patients
по: Abedin, Minhajul, и др.
Опубликовано: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
по: Rithin, Rafia Islam
Опубликовано: (2022)

A review on adult neurogenesis in Alzheimer’s disease
по: Akter, Moriam
Опубликовано: (2022)

Gene editing for neurodegenerative diseases-A review
по: Sharna, Anika Islam
Опубликовано: (2023)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
по: Roy, Aditya, и др.
Опубликовано: (2023)

Early detection of lung cancer risk using data mining
по: Ahmed, Kawsar, и др.
Опубликовано: (2016)

Deep learning based early Glaucoma detection
по: Islam, Aabrar, и др.
Опубликовано: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
по: Sani, Mehedi Hasan, и др.
Опубликовано: (2022)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
по: Mahbub, Riasat, и др.
Опубликовано: (2022)

The role of Artificial Intelligence (AI) in the detection and diagnosis of chronic diseases – a review
по: Zaman, Mumtahina
Опубликовано: (2022)

In vivo evaluation of CNS depressant and antinociceptive activities of different extracts of trewia polycarpa leaves
по: Akter, Nahid
Опубликовано: (2015)